| Database ID | Agent | Target | Cancer Type | Detail |
| DB00796 | everolimus | Serine/threonineprotein kinase mTOR | non small cell lung cancer | view |
| DB00797 | cediranib | Vascular endothelial growth factor receptor 2 | smallcell lung cancer | view |
| DB00798 | Cetuximab | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00799 | dalotuzumab | The insulinlike growth factor receptor | smallcell lung cancer | view |
| DB00800 | cediranib | Vascular endothelial growth factor receptor 2 | non small cell lung cancer | view |
| DB00801 | cediranib | Vascular endothelial growth factor receptor 2 | non small cell lung cancer | view |
| DB00802 | OGX011 | mRNA of Clusterin | breast cancer | view |
| DB00803 | cediranib | Vascular endothelial growth factor receptor 2 | non small cell lung cancer | view |
| DB00804 | cetuximab | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00805 | selumetinib | Dual specificity mitogenactivated protein kinase kinase | non small cell lung cancer | view |
| DB00806 | dacomitinib | Epidermal growth factor receptor, Proto oncogene proteinc mdm2, Erbb2 tyrosine kinase receptor | lung cancer | view |
| DB00807 | dacomitinib | Epidermal growth factor receptor, Proto oncogene proteinc mdm2, Erbb2 tyrosine kinase receptor | non small cell lung cancer | view |
| DB00808 | erlotinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00809 | dacomitinib | Epidermal growth factor receptor, Proto oncogene proteinc mdm2, Erbb2 tyrosine kinase receptor | non small cell lung cancer | view |
| DB00810 | erlotinib, SAR245409 | SAR245409: Phosphoinositide 3 kinase
Serine/threonineprotein kinase mTOR | advanced solid tumors | view |